Turn Therapeutics TTRX
NASDAQ TTRX
$10.20 -0.27 (-2.53%)
As of: Oct 21, 2026 · 3:01 PM EDT

Turn Therapeutics (TTRX) Current Assets (2024 - 2026)

Updated

Turn Therapeutics' Current Assets came in at $10.43 million for Q2 2026, down 8.9% from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Turn Therapeutics' Current Assets was $5.2 million, up 373.3% from FY2024.

  • Going back by year, Current Assets was $1.1 million in FY2024.
  • The five-year range for quarterly Current Assets is $1.1 million (Q4 2024) to $11.45 million (Q1 2026).
  • Business Quant data shows TTRX's Current Assets at $11.45 million (Q1 2026), $5.2 million (Q4 2025) and $3.29 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,136.82 Bn 1,105.41 Bn 19.71 Bn 64.67 Bn
2 Johnson & Johnson 617.41 Bn 535.94 Bn 17.26 Bn 59.77 Bn
3 AbbVie 501.29 Bn 474.40 Bn 12.70 Bn 33.67 Bn
4 Merck 368.15 Bn 322.53 Bn 12.21 Bn 36.68 Bn
5 Novartis Ag 297.07 Bn 261.06 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 260.90 Bn 234.58 Bn 12.86 Bn 27.97 Bn
7 Amgen 236.34 Bn 191.74 Bn 7.24 Bn 34.96 Bn
8 Gilead Sciences 191.00 Bn 165.20 Bn 6.22 Bn 13.95 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn 41.36 Bn
10 Turn Therapeutics 306.82 Mn 279.93 Mn - 10.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.43 Mn
Mar 31, 2026 11.45 Mn
Dec 31, 2025 5.20 Mn
Sep 30, 2025 3.29 Mn
Dec 31, 2024 1.10 Mn
API Access

Turn Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=TTRX&period=max&api_key=YOUR_API_KEY